Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 4 × Prolactinoma × Cabergoline × Clear all

Phase

Phase NA 2 Phase 4 1 Phase 3 1 Phase 2/3 1

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Conditions

Pituitary Neoplasms 3 Acromegaly 2 Prostatic Neoplasms 1 Prolactinoma 1 Prolactin Deficiency, Isolated 1 Pituitary ACTH Hypersecretion 1 Neuroendocrine Tumors 1 Neoplasms 1 Melanoma 1 Hyperprolactinemia 1 Dumping Syndrome 1 Brain Neoplasms 1

Interventions

Dopamine Agonists 2 Standard of Care 1 Cabergoline 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT07045935 2025-09-23

ProBOLIC

University Hospital, Basel, Switzerland

Phase 4 Recruiting

Prolactin Deficiency, Isolated, Hyperprolactinemia, Prolactinoma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡